Earnings To Watch: Lifecore Biomedical Inc (LFCR) Reports Q2 2025 Result [Yahoo! Finance]
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q2 2025 revenue is $29.75 million, and the earnings are expected to come in at -$0.29 per share. The full year 2025's revenue is expected to be $128.55 million and the earnings are expected to be -$0.92 per share. More detailed estimate data can be found on the Forecast page Lifecore Biomedical Inc ( NASDAQ:LFCR ) Estimates Trends Warning! GuruFocus has detected 4 Warning Signs with LFCR. Over the past 90 days, revenue estimates for Lifecore Biomedical Inc ( NASDAQ:LFCR ) have increased from $127.56 million to $128.55 million for the full year 2025. For 2026, revenue estimates have risen from $137.49 million to $139.35 million. Similarly, earnings estimates have improved from -$1.01 per share to -$0.92 per share for the full year 2025, and from -$0.75 per share to -$0.65 per share for 2026. Lifecore Biomedical Inc ( NASDAQ:LFCR ) Reported History In the previous quarter ending on August 31, 2024, Lifecore Biomedical Inc's ( NASDAQ:LFCR ) actual rev
Show less
Read more
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach OutAccesswire
- Lifecore Biomedical, Inc. (NASDAQ: LFCR) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $6.00 price target on the stock.MarketBeat
- Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
- Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire
LFCR
Sec Filings
- 12/10/24 - Form 4
- 12/10/24 - Form 4
- 11/12/24 - Form SC
- LFCR's page on the SEC website